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The objective of this study is to develop a novel system for cutaneous
application of ACV that is capable of a controlled release of the drug
overcoming the limitations of the conventional topical formulations.
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ACV: intermediate/low aqueous solubility;
low permeability in biological tissues.
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• Low bioavailability;
• Repeated administration 
of high doses.
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RESULTS and DISCUSSION:
1.1 Control Release Assays 
(pH 5.5 at Temp=37 ºC in micellar environment)
2.1 Scanning Electron Microscopy
Elemental Analysis (SEM-EDS) 
Visualization of ACV-loaded PCL
nanofibers by Scanning Electron
Microscopy with Energy-Dispersive X-ray
Spectroscopy (SEM-EDS) with 15 kV,
dimensions 380 x 380 µm.
ACV
PCL
1-A: ACV-loaded zein nanofiber
1. SELECTION OF THE BEST SYSTEM 2. CHARACTERIZATION THE BEST SYSTEM 
1-B: ACV-loaded PCL nanofiber
2.2 Structural Characterization by X-
ray Diffraction 
2.5 Cell Viability 
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CONCLUSION:
The electrospinning technique proved to be efficient in producing high-loaded ACV nanofibers. The PCL
nanofibers are very resistant and elastic (Fig. 1-B) when compared with zein nanofibers, being a promising
approach to reach a sustained drug release profile.
- The main difference between PCL and ACV spectra is observed at the fingerprint IR region (600-1000 cm-1) which can be
difficult to assign to specific vibrations. However the fingerprint bands 1, 2 and 3 are present both in IR spectra of ACV and
of PCL nanofibers containing ACV being absent in PCL nanofibers IR spectrum which is a proof of ACV presence at PCL
nanofibers.
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2.3 Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy (ATR-FTIR)
DISCUSSION:
1) The developed systems present a more sustained drug release profile when
compared with commercial formulation. The system that presents better
resistance and mechanical properties is the PCL nanofibers matrix.
2) Characterization of ACV-Loaded PCL Nanofibers:
2.1) SEM-EDS shows the presence of ACV in the nanofiber. ACV loaded nanofibers
have an average size of 595 nm.
2.2) X-ray diffraction shows the presence of nanocrystals of ACV in the nanofiber.
2.3) ATR-FTIR shows the presence of ACV in the nanofiber.
2.4) DSC indicates that ACV reduces the melting enthalpy without changing Tm of
the PCL polymer. This suggests presence of ACV within PCL nanofiber reducing
PCL crystallinity but preserving its melting temperature high over body temperature.
Thus ACV incorporation in PCL nanofiber preserves its integrity.
2.5) The nanofibers presented acceptable cell viability up to a concentration of
25 mg/mL.
Y=Ftmax (1-e
-k1.t) 
´R2 > 0,92
Viability of epidermal keratinocytes - HaCaT (left) and human foreskin fibroblasts HFF-1 (right) assessed by the MTT
assay after 24 h incubation with extracts of PCL fibers and hydrophilic gauze. Columns represent mean values and
error bars the standard deviation (n=3).
2.4 Differential Scanning Calorimetry (DSC) 
consequently
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- Another distinctive region is the region of
1400-1750 cm-1 where it is possible to assign
vibrations due to ACV monosubstituted amide
(CO-N-H). CNH stretch-bend appears at
1570-1510 cm-1 (4) and C=O stretch band of
ACV appears at 1630-1680 cm-1 (5)
- At 3200 to 3600 cm−1, the N–H vibration of
ACV primary and secondary amines can be
found and do not appear at PCL nanofibers
IR spectrum, but are present at IR spectrum
of PCL nanofibers containing ACV.
No changes in melting temperature of PCL
upon incorporation of ACV (Tm=56,7 ºC)
ΔH = 56,3 J/g
ΔH = 38,2 J/g
ACV
